Business Context and Reporting Period
Company: HealthSouth Corporation (Note: Filing text identifies registrant as HealthSouth; metadata references Encompass Health, which is the successor entity).
Reporting Period: Quarterly period ended September 30, 2007 (Form 10-Q).
Strategic Position: The Company is executing a strategic repositioning to become a "pure-play" provider of inpatient rehabilitation services. During the nine months ended September 30, 2007, HealthSouth completed the divestiture of its Surgery Centers, Outpatient, and Diagnostic divisions. Proceeds from these sales were primarily used to reduce long-term debt.
Key Financial Metrics
| Metric (in millions) | Three Months Ended Sep 30, 2007 | Nine Months Ended Sep 30, 2007 | Nine Months Ended Sep 30, 2006 |
|---|---|---|---|
| Net Operating Revenues | $431.6 | $1,313.5 | $1,288.8 |
| Net Income (Loss) | $287.6 | $699.2 | $(553.7) |
| Net Income Available to Common Shareholders | $281.1 | $679.7 | $(569.4) |
| EPS (Diluted) | $3.13 | $7.61 | $(7.16) |
| Operating Cash Flow | N/A | $(145.6) | $(79.3) |
| Total Debt Outstanding | $2,392.8 | $2,392.8 | $3,376.7 |
| Cash and Cash Equivalents | $15.9 | $15.9 | $27.1 |
Continuing vs. Discontinued Operations: The significant net income for the nine months ended September 30, 2007, is driven largely by income from discontinued operations ($475.7 million), primarily due to gains on the divestiture of the Surgery Centers, Outpatient, and Diagnostic divisions. Income from continuing operations was $223.5 million.
Material Changes vs. Prior Period
- Revenue Growth: Net operating revenues increased 4.4% for the quarter and 1.9% for the nine-month period compared to 2006. This growth is attributed to an increase in the patient case mix index and compliant case growth in inpatient rehabilitation, offset by decreased outpatient volumes.
- Profitability Turnaround: The Company reported a net income of $699.2 million for the nine months ended September 30, 2007, compared to a net loss of $553.7 million in the prior year period. This reversal is primarily due to:
- Significant gains on the sale of discontinued divisions ($443.6 million gain on divestiture).
- A substantial income tax benefit of $288.2 million, largely driven by a $440 million federal income tax refund received in October 2007 (accrued in Q3) related to tax years 1996-1999.
- Reductions in "Government, class action, and related settlements expense" and "Professional fees" compared to the prior year.
- Debt Reduction: Total debt decreased from $3.4 billion as of December 31, 2006, to approximately $2.4 billion as of September 30, 2007. This reduction was funded by divestiture proceeds and the aforementioned tax refund.
- Operating Expenses: General and administrative expenses decreased 24.7% for the quarter and remained flat for the nine-month period, reflecting the divestiture of non-core divisions and cost rationalization.
Guidance, Outlook, Risks, and Unusual Items
- Unusual Items:
- Tax Refund: A $440 million cash refund from the IRS (including interest) was received in October 2007. Approximately $405 million was used to pay down debt.
- Divestiture Gains: Gains on the sale of Surgery Centers ($317.8 million), Outpatient ($134.2 million), and Diagnostic divisions (loss of $8.4 million) are classified as discontinued operations.
- Scrushy Recovery: The prior year period included a $35.0 million recovery of amounts due from former CEO Richard M. Scrushy, which is not present in the current period.
- Outlook: Management expects to continue rationalizing corporate overhead. The Company anticipates declining volumes in the fourth quarter as hospitals adjust to higher compliance thresholds under the "75% Rule" for Medicare reimbursement. However, the Company plans to pursue growth through bed expansion, consolidation, and new facility development.
- Risks and Contingencies:
- Leverage: The Company remains highly leveraged. A substantial downturn in operating earnings could impair compliance with financial covenants in the Credit Agreement.
- Regulatory Compliance: The "75% Rule" (requiring 75% of patients to have specific primary diagnoses) poses a risk to revenue if compliance thresholds are not met.
- Legal Proceedings: Ongoing litigation includes disputes with former partners, insurance coverage litigation, and potential claims from opt-out class members in securities litigation. The Company has recorded liabilities for settlements but notes that final amounts may vary.
- Guarantees: The Company is secondarily liable for approximately $138.9 million in guarantees related to sold facilities, though no liability has been recorded as performance is not considered probable.
Investor Verification Checklist
- Debt Covenant Compliance: Verify the Company's ability to meet financial covenants under its Credit Agreement given the high leverage ratio and reliance on operating cash flow.
- Tax Refund Utilization: Confirm the full application of the $440 million IRS refund toward debt reduction and the impact on future interest expense.
- Divestiture Closing: Monitor the final regulatory approvals for the remaining facilities in the Surgery Centers and Outpatient divestitures to ensure full realization of deferred proceeds.
- 75% Rule Impact: Assess the impact of the 75% Rule compliance thresholds on patient volumes and revenue in the fourth quarter of 2007 and beyond.
- Legal Settlements: Review the status of the Medicare Program Settlement (final payment due December 2007) and ongoing securities litigation to estimate future cash outflows.
- Continuing Operations Performance: Analyze the underlying profitability of the continuing inpatient rehabilitation business excluding the one-time gains from discontinued operations and tax benefits.